{
    "Trade/Device Name(s)": [
        "cobas\u00ae Cdiff Nucleic Acid Test for use on the cobas\u00ae Liat\u00ae System"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K212427",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171770"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN",
        "OOI"
    ],
    "Summary Letter Date": "August 3, 2021",
    "Summary Letter Received Date": "August 4, 2021",
    "Submission Date": "July 29, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "Clostridium Difficile Toxin Gene Amplification Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Clostridioides difficile toxin B (tcdB) gene"
    ],
    "Specimen Type(s)": [
        "Unformed (liquid or soft) stool"
    ],
    "Specimen Container(s)": [
        "cobas\u00ae PCR Media Swab Sample Kit"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae Liat\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Silica magnetic particle-based nucleic acid extraction",
        "TaqMan probe-based detection",
        "Automated nucleic acid amplification"
    ],
    "Methodologies": [
        "Nucleic acid extraction",
        "Real-time PCR",
        "Molecular amplification",
        "Multiplex assay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Analyzer",
        "Tube",
        "Reagent",
        "Software",
        "Sample preparation",
        "Detection system"
    ],
    "Document Summary": "FDA 510(k) summary for cobas\u00ae Cdiff nucleic acid test utilizing real-time PCR to detect C. difficile toxin B gene in stool on the cobas\u00ae Liat\u00ae System",
    "Indications for Use Summary": "Automated qualitative in vitro diagnostic test using real-time PCR to detect toxin B (tcdB) gene of toxigenic Clostridioides difficile in unformed stool specimens from patients suspected of C. difficile infection, as an aid in diagnosis used with clinical and epidemiological risk factors",
    "fda_folder": "Microbiology"
}